Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2022
23 minute read | July.27.2022
Evolving Antitrust Scrutiny of Life Sciences M&A—What's in the Pipeline?
Search Results
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2022
April.26.2022
A Conversation on Leveraging Spinouts to Preserve and Create Value During Financing Rounds, M&A and IPO Planning
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q1 2022
22 minute read | February.16.2022
A Conversation on the Future of Longevity, Cell Regeneration and Senescence
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q4 2021
23 minute read | October.19.2021
VC Investment Surges in European Life Science
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q3 2021
14 minute read | July.21.2021
A Conversation on Spinouts – Unlocking Market Value and Creating Business Opportunities
Insight
Royalty Licensing Insurrection in Life Sciences
by David Schulman and Alyssa Barnard-Yanni
July.19.2021
Orrick’s David Schulman and Alyssa Barnard-Yanni have co-authored an article in Intellectual Property magazine that discusses the recent fallout from ...
Insight
Life Sciences Snapshot – A Quarterly Report on Financing Trends – Q2 2021
22 minute read | April.20.2021
Record-breaking Markets and a Candid Conversation on University Spinouts